MG-2119

• Description :

  MG-2119 is a potent monomeric tau and α-syn aggregation inhibitor. MG-2119 is a potential agent for neurological disorders research[1].

• UNSPSC :

  12352005

• Target :

  Tau Protein

• Type :

  Reference compound

• Related Pathways :

  Neuronal Signaling

• Applications :

  Neuroscience-Neurodegeneration

• Field of Research :

  Neurological Disease

• Assay Protocol :

  https://www.medchemexpress.com/mg-2119.html

• Concentration :

  10mM

• Purity :

  99.67

• Solubility :

  DMSO : 100 mg/mL (ultrasonic)

• Smiles :

  O=C(C1=CC(NC(COC)=O)=CC2=C1N(CCC3=CC=CC=C3)C=N2)NCC(C)OC4=CC=CN=C4

• Molecular Formula :

  C27H29N5O4

• Molecular Weight :

  487.55

• References & Citations :

  [1]Gabr MT, et al. Dual Targeting of Monomeric Tau and α-Synuclein Aggregation: A New Multitarget Therapeutic Strategy for Neurodegeneration. ACS Chem Neurosci. 2020;11 (14) :2051-2057.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  4°C (Powder, sealed storage, away from moisture and light)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [1065500-40-4]